Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 155,927 | 109,685 | 68,905 | 179,160 | 182,574 |
| Receivables | 220,630 | 203,001 | 184,810 | 192,972 | 190,101 |
| Inventories | 89,396 | 88,470 | 92,969 | 100,297 | 102,723 |
| Other current assets | 86,597 | 84,096 | 79,159 | 80,465 | 120,203 |
| TOTAL | $552,550 | $485,252 | $425,843 | $552,894 | $595,601 |
| Non-Current Assets | |||||
| PPE Net | 676,182 | 717,020 | 738,030 | 752,657 | 863,744 |
| Intangibles | 315,238 | 293,531 | 290,998 | 319,674 | 661,815 |
| Other Non-Current Assets | 88,786 | 90,541 | 103,449 | 108,148 | 82,933 |
| TOTAL | $1,080,206 | $1,101,092 | $1,132,477 | $1,180,479 | $1,608,492 |
| Total Assets | $1,632,756 | $1,586,344 | $1,558,320 | $1,733,373 | $2,204,093 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 21,437 | 139,384 | 14,758 | 30,582 | 35,413 |
| Accounts payable and accrued liabilities | 31,770 | 31,218 | 34,332 | 30,627 | 31,218 |
| Accrued Expenses | 115,173 | 92,159 | 95,979 | 108,287 | 94,046 |
| Other current liabilities | 22,546 | 21,262 | 14,033 | 20,095 | 15,219 |
| TOTAL | $247,034 | $342,247 | $216,797 | $259,780 | $249,773 |
| Non-Current Liabilities | |||||
| Long Term Debt | 642,352 | 527,136 | 703,187 | 670,270 | 457,419 |
| Deferred Revenues | 54,177 | 56,422 | 56,530 | 66,905 | 71,114 |
| aiOther Non-Current Liabilities | 97,970 | 113,190 | 110,562 | 120,044 | 124,916 |
| TOTAL | $741,645 | $640,897 | $814,160 | $784,866 | $580,496 |
| Total Liabilities | $988,679 | $983,144 | $1,030,957 | $1,044,646 | $830,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 47,659 | 48,182 | 48,887 | 56,478 | 65,888 |
| Common Shares | 825 | 796 | 785 | 775 | 771 |
| Retained earnings | -265,473 | -368,301 | -465,596 | -575,162 | -238,493 |
| Other shareholders' equity | 8,570 | 9,389 | 6,253 | 35,240 | 44,091 |
| TOTAL | $644,077 | $603,200 | $527,363 | $688,727 | $1,373,824 |
| Total Liabilities And Equity | $1,632,756 | $1,586,344 | $1,558,320 | $1,733,373 | $2,204,093 |